Clinical Research and Guidelines Infographics

Proprotein convertase subtilisin/kexin type 9 (PCSK9) is involved in cholesterol homeostasis and inflammation, platelet activation, and atherosclerosis disease progression.
This infographic presents the physiological functions and molecular features that make PCSK9 an attractive therapeutic target for cardiovascular diseases.
Various strategies for targeting PCSK9 and clinical trials involving PCSK9-inhibitors are also delineated.

First published: March 21, 2024  

In this infographic, we look at current treatment strategies and future innovations.

First published: November 8, 2023  

This infographic summarizes the key take home messages of the World Heart Federation’s Cholesterol Roadmap.

First published: March 3, 2023  

Check out and download our latest infographic based on the 2022 Expert Consensus Decision Pathway by the American College of Cardiology – Role of Nonstatin Therapies in Lowering LDL-Cholesterol during ASCVD Risk Management.

First published: November 3, 2022  

This infographic summarizes the key takeaway messages from the recently published National Lipid Association (NLA) Scientific Statement on Lipid Measurements in the Management of Cardiovascular Diseases.

First published: October 21, 2021  

There was a lot to process from the latest ESC guidance on CVD prevention. This infographic focusses on the key updates in ASCVD and lipidology, which revolved around the importance of risk assessment and the best time to initiate treatment.

First published: September 16, 2021